Dissecting the role of sortilin receptor signaling in neurodegeneration induced by NGF deprivation

Biochemical and Biophysical Research Communications

Volumn 431, Issue 3, 2013, Pages 579-585

  Capsoni, Simona ^a,b   Amato, Gianluca ^b   Vignone, Domenico ^b   Criscuolo, Chiara ^b,d   Nykjaer, Anders ^c   Cattaneo, Antonino ^a,b  

^a SCUOLA NORMALE SUPERIORE   (Italy)

^b EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^c AARHUS UNIVERSITY   (Denmark)

^d UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Alzheimer's disease; Amyloid ; Choline acetyltransferase; ProNGF; Sortilin; Tau

Indexed keywords

AMYLOID PRECURSOR PROTEIN; NERVE GROWTH FACTOR; PROTEIN TYROSINE KINASE A; SORTILIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; FEMALE; LEARNING; MALE; MEMORY; MEMORY DISORDER; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RECOGNITION; SIGNAL TRANSDUCTION; SPATIAL MEMORY; VISUAL MEMORY; WORKING MEMORY;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CHOLINE; CHOLINERGIC NEURONS; DISEASE MODELS, ANIMAL; MEMORY DISORDERS; MICE; MICE, MUTANT STRAINS; NERVE GROWTH FACTOR; NEURITIS; PHOSPHORYLATION; PROTEIN MODIFICATION, TRANSLATIONAL; RECEPTOR, TRKA; SIGNAL TRANSDUCTION; TAU PROTEINS;

MUS;

EID: 84873744036     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.01.007     Document Type: Article

References (36)

1. Lee R., Kermani P., Teng K.K., Hempstead B.L. Regulation of cell survival by secreted proneurotrophins. Science 2001, 294:1945-1948.
2. Skeldal S., Matusica D., Nykjaer A., Coulson E.J. Proteolytic processing of the p75 neurotrophin receptor: A prerequisite for signalling?: Neuronal life, growth and death signalling are crucially regulated by intra-membrane proteolysis and trafficking of p75(NTR). Bioessays 2011, 33:614-625.
3. Capsoni S., Ugolini G., Comparini A., Ruberti F., Berardi N., Cattaneo A. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc. Natl. Acad. Sci. USA 2000, 97:6826-6831.
4. Ruberti F., Capsoni S., Comparini A., Di Daniel E., Franzot J., Gonfloni S., Rossi G., Berardi N., Cattaneo A. Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy. J. Neurosci. 2000, 20:2589-2601.
5. Cattaneo A., Capsoni S., Paoletti F. A new generation of non invasive NGF-based therapies for Alzheimer's disease. Emerging drugs Targets for Alzheimer's disease 2009, RCS Publishing. A. Martinez (Ed.).
6. Capsoni S., Cattaneo A. On the molecular basis linking nerve growth factor (NGF) to Alzheimer's disease. Cell. Mol. Neurobiol. 2006, 26:619-633.
7. Capsoni S., Tiveron C., Vignone D., Amato G., Cattaneo A. Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration. Proc. Natl. Acad. Sci. USA 2010, 107:12299-12304.
8. Capsoni S., Tiveron C., Amato G., Vignone D., Cattaneo A. Peripheral neutralization of nerve growth factor induces immunosympathectomy and central neurodegeneration in transgenic mice. J. Alzheimers Dis. 2010, 20:527-546.
9. Jansen P., Giehl K., Nyengaard J.R., Teng K., Lioubinski O., Sjoegaard S.S., Breiderhoff T., Gotthardt M., Lin F., Eilers A., Petersen C.M., Lewin G.R., Hempstead B.L., Willnow T.E., Nykjaer A. Roles for the pro-neurotrophin receptor sortilin in neuronal development, aging and brain injury. Nat. Neurosci. 2007, 10:1449-1457.
10. Capsoni S., Marinelli S., Ceci M., Vignone D., Amato G., Malerba F., Paoletti F., Meli G., Viegi A., Pavone F., Cattaneo A. Intranasal " painless" human nerve growth factor slows amyloid neurodegeneration and prevents memory deficits in App X PS1 mice. PLoS One 2012, 7:e37555.
11. Capsoni S., Giannotta S., Cattaneo A. Beta-amyloid plaques in a model for sporadic Alzheimer's disease based on transgenic anti-nerve growth factor antibodies. Mol. Cell. Neurosci. 2002, 21:15-28.
12. Capsoni S., Covaceuszach S., Ugolini G., Spirito F., Vignone D., Stefanini B., Amato G., Cattaneo A. Delivery of NGF to the brain: Intranasal versus ocular administration in Anti-NGF transgenic mice. J. Alzheimers Dis. 2009, 16:371-388.
13. Mobley W.C., Rutkowski J.L., Tennekoon G.I., Gemski J., Buchanan K., Johnston M.V. Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons. Brain Res. 1986, 387:53-62.
14. Nykjaer A., Willnow T.E. Sortilin: a receptor to regulate neuronal viability and function. Trends Neurosci. 2012, 35:261-270.
15. Gliemann J., Hermey G., Nykjaer A., Petersen C.M., Jacobsen C., Andreasen P.A. The mosaic receptor sorLA/LR11 binds components of the plasminogen-activating system and platelet-derived growth factor-BB similarly to LRP1 (low-density lipoprotein receptor-related protein), but mediates slow internalization of bound ligand. Biochem. J. 2004, 381:203-212.
16. Teng H.K., Teng K.K., Lee R., Wright S., Tevar S., Almeida R.D., Kermani P., Torkin R., Chen Z.Y., Lee F.S., Kraemer R.T., Nykjaer A., Hempstead B.L. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J. Neurosci. 2005, 25:5455-5463.
17. Tauris J., Gustafsen C., Christensen E.I., Jansen P., Nykjaer A., Nyengaard J.R., Teng K.K., Schwarz E., Ovesen T., Madsen P., Petersen C.M. Proneurotrophin-3 may induce Sortilin-dependent death in inner ear neurons. Eur. J. Neurosci. 2011, 33:622-631.
18. Vaegter C.B., Jansen P., Fjorback A.W., Glerup S., Skeldal S., Kjolby M., Richner M., Erdmann B., Nyengaard J.R., Tessarollo L., Lewin G.R., Willnow T.E., Chao M.V., Nykjaer A. Sortilin associates with trk receptors to enhance anterograde transport and neurotrophin signaling. Nat. Neurosci. 2011, 14:54-61.
19. D'Onofrio M., Arisi I., Brandi R., Di Mambro A., Felsani A., Capsoni S., Cattaneo A. Early inflammation and immune response mRNAs in the brain of AD11 anti-NGF mice. Neurobiol. Aging 2011, 32:1007-1022.
20. Mazella J., Zsurger N., Navarro V., Chabry J., Kaghad M., Caput D., Ferrara P., Vita N., Gully D., Maffrand J.P., Vincent J.P. The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. J. Biol. Chem. 1998, 273:26273-26276.
21. Hu F., Padukkavidana T., Vaegter C.B., Brady O.A., Zheng Y., Mackenzie I.R., Feldman H.H., Nykjaer A., Strittmatter S.M. Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin. Neuron 2010, 68:654-667.
22. Giordano V., Peluso G., Iannuccelli M., Benatti P., Nicolai R., Calvani M. Systemic and brain metabolic dysfunction as a new paradigm for approaching Alzheimer's dementia. Neurochem. Res. 2007, 32:555-567.
23. Pickford F., Marcus J., Camargo L.M., Xiao Q., Graham D., Mo J.R., Burkhardt M., Kulkarni V., Crispino J., Hering H., Hutton M. Progranulin is a chemoattractant for microglia and stimulates their endocytic activity. Am. J. Pathol. 2011, 178:284-295.
24. Ferrier I.N., Cross A.J., Johnson J.A., Roberts G.W., Crow T.J., Corsellis J.A., Lee Y.C., O'Shaughnessy D., Adrian T.E., McGregor G.P., et al. Neuropeptides in Alzheimer type dementia. J. Neurol. Sci. 1983, 62:159-170.
25. Benzing W.C., Mufson E.J., Jennes L., Armstrong D.M. Reduction of neurotensin immunoreactivity in the amygdala in Alzheimer's disease. Brain Res. 1990, 537:298-302.
26. Nemeroff C.B., Kizer J.S., Reynolds G.P., Bissette G. Neuropeptides in Alzheimer's disease: A postmortem study. Regul. Pept. 1989, 25:123-130.
27. Azmi N., Norman C., Spicer C.H., Bennett G.W. Effects of a neurotensin analogue (PD149163) and antagonist (SR142948A) on the scopolamine-induced deficits in a novel object discrimination task. Behav. Pharmacol. 2006, 17:357-362.
28. Brouwers N., Sleegers K., Engelborghs S., Maurer-Stroh S., Gijselinck I., van der Zee J., Pickut B.A., Van den Broeck M., Mattheijssens M., Peeters K., Schymkowitz J., Rousseau F., Martin J.J., Cruts M., De Deyn P.P., Van Broeckhoven C. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease. Neurology 2008, 71:656-664.
29. Cortini F., Fenoglio C., Guidi I., Venturelli E., Pomati S., Marcone A., Scalabrini D., Villa C., Clerici F., Dalla Valle E., Mariani C., Cappa S., Bresolin N., Scarpini E., Galimberti D. Novel exon 1 progranulin gene variant in Alzheimer's disease. Eur. J. Neurol. 2008, 15:1111-1117.
30. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 2002, 297:353-356.
31. Small S.A., Duff K. Linking abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis. Neuron 2008, 60:534-542.
32. Capsoni S., Brandi R., Arisi I., D'Onofrio M., Cattaneo A. A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model. CNS Neurol. Disord. Drug Targets 2011, 10:635-647.
33. Pallesen L.T., Vaegter C.B. Sortilin and SorLA regulate neuronal sorting of trophic and dementia-linked proteins. Mol. Neurobiol. 2012, 45:379-387.
34. Fortress A.M., Buhusi M., Helke K.L., Granholm A.C. Cholinergic degeneration and alterations in the TrkA and p75NTR balance as a result of pro-NGF injection into aged rats. J. Aging Res. 2011, 2011:460543.
35. Gustafsen C., Glerup S., Pallesen L.T., Olsen D., Andersen O.M., Nykjær A., Madsen P., Petersen C.M. Sortilin and SorLA display distinct roles in processing and trafficking of amyloid precursor protein. J. Neurosci. 2013, 33:64-71.
36. Carlo A.S., Gustafsen C., Mastrobuoni G., Nielsen M.S., Burgert T., Hartl D., Rohe M., Nykjaer A., Herz J., Heeren J., Kempa S., Petersen C.M., Willnow T.E. The pro-neurotrophin receptor sortilin is a major neuronal APOE receptor for catabolism of amyloid-peptide in the brain. J. Neurosci. 2013, 33:358-370.